Koyfin Home > Directory > Health Care > ANI Pharma Inc > Net Debt / (EBITDA-CAPEX)

ANI Pharma Inc Net Debt / (EBITDA-CAPEX) Chart (ANIP)

ANI Pharma Inc annual/quarterly Net Debt / (EBITDA-CAPEX) from 2012 to 2020.
  • ANI Pharma Inc Net Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $6m a 63.05% increase of 4m year over year
  • ANI Pharma Inc Net Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $6m a 70.59% increase of 4m year over year
  • ANI Pharma Inc Annual Net Debt / (EBITDA-CAPEX) for 2019 was $2m a 14.42% increase of 0m from 2018
  • ANI Pharma Inc Annual Net Debt / (EBITDA-CAPEX) for 2018 was $2m a -78.69% decrease of -2m from 2017
  • ANI Pharma Inc Annual Net Debt / (EBITDA-CAPEX) for 2017 was $4m a 50.49% increase of 2m from 2016
Other Ratios Metrics:
  • ANI Pharma Inc Total Debt / Capital for the quarter ending December 12, 2018 was $48m a -10.11% decrease of -5m year over year
  • ANI Pharma Inc Other Liabilities for the quarter ending December 12, 2018 was $0m a -404.03% decrease of -2m year over year
  • ANI Pharma Inc Total Debt / Equity for the quarter ending December 12, 2018 was $93m a -21.52% decrease of -20m year over year
View Chart On Koyfin

Quarterly ANIP Net Debt / (EBITDA-CAPEX) Data

06/2020$6m
03/2020$26m
12/2019$10m
09/2019$2m
06/2019$2m
03/2019$2m
12/2018$2m
09/2018$2m
06/2018$2m
03/2018$3m

Annual ANIP Net Debt / (EBITDA-CAPEX) Data

2019$2m
2018$2m
2017$4m
2016$2m
2015$-1m
2014$-3m
2013$-2m
2012$4m
2011$48m